Treatment of Progesterone Dermatitis
The most effective treatment for progesterone dermatitis is ovulation suppression using combined oral contraceptive pills (OCPs) as first-line therapy to prevent endogenous progesterone production.
Understanding Progesterone Dermatitis
Progesterone dermatitis, also known as autoimmune progesterone dermatitis (AIPD), is a rare autoimmune reaction to endogenous progesterone characterized by:
- Cyclical cutaneous eruptions that occur during the luteal phase of the menstrual cycle
- Symptoms typically beginning 3-10 days before menstruation and resolving 1-2 days after menstruation ceases 1, 2
- Various presentations including eczematous eruptions, urticaria, erythema multiforme, folliculitis, and angioedema 3
Diagnostic Approach
Diagnosis is confirmed through:
- Correlation of skin eruptions with the menstrual cycle
- Intradermal skin testing with progesterone (development of a wheal confirms diagnosis) 4, 1
- Exclusion of other cyclical dermatoses
Treatment Algorithm
First-Line Treatment:
- Combined oral contraceptive pills containing ethinyl estradiol and a progestin 4, 3
- Example regimen: 30 mcg ethinyl estradiol with 0.15 mg levonorgestrel in a continuous regimen
- Mechanism: Suppresses ovulation, preventing endogenous progesterone production
Second-Line Options (if OCPs fail or are contraindicated):
Gonadotropin-releasing hormone (GnRH) analogues 1, 5
- Effectively suppresses ovulation
- Limited by potential side effects (bone loss) and cost
- Suppresses pituitary gonadotropins
- Monitor for androgenic side effects
Tamoxifen 4
- Less commonly used
- Consider in patients with contraindications to hormonal therapy
Last Resort:
- Surgical intervention (oophorectomy) 4, 5
- Reserved for severe, refractory cases
- Permanent solution but carries surgical risks and induces menopause
Treatment Considerations
Ineffective treatments to avoid:
Monitoring:
- Evaluate response after 2-3 menstrual cycles
- Adjust treatment if symptoms persist
Pitfalls and Caveats
- Progesterone dermatitis is frequently misdiagnosed as allergic contact dermatitis or other recurrent eczematous conditions 1
- Consider this diagnosis in women with treatment-refractory, cyclical skin eruptions
- The condition may first present or worsen after exposure to exogenous progesterone or during pregnancy 2
- Multiple subtypes likely exist, explaining variations in presentation and treatment response 2
Prognosis
With appropriate ovulation suppression therapy, most patients experience significant improvement or complete resolution of symptoms. Some patients may require long-term therapy until natural menopause occurs.